首页 >
法规速递
-
Page: Good Manufacturing Practice (GMP) / Distribution Practice Practice (GDP) Inspectors Working Group-2025/5/8
2025-05-09查看详情 > -
Page: Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline-2025/6/17
2025-06-18查看详情 > -
Document: Network Data Steering Group workplan 2025-2028-2025/7/22
2025-07-23查看详情 > -
关于公开征求《神经病理性疼痛治疗药物临床试验技术指导原则（征求意见稿）》意见的通知-2025/9/8
2025-09-09查看详情 > -
国家药监局综合司公开征求《国家药监局 国家卫生健康委 国家中医药局关于进一步推进药品上市许可持有人加快开展中药注射剂上市后研究和评价工作的公告（征求意见稿）》意见-2025/10/9
2025-10-10查看详情 > -
Document: Severe cutaneous adverse reactions - standard template wording for product information-2025/11/17
2025-11-18查看详情 > -
2025年12月12日中药品种保护受理公示-2025/12/12
2025-12-15查看详情 > -
Document: SMS guidance for external users-2026/1/23
2026-01-26查看详情 > -
Document: Consolidated 3-year work plan for the clinical domain-2026/3/3
2026-03-04查看详情 > -
Document: Annex 4 - Initial Qualification Procedure List of Issues and Replies - Virtual Control Groups-2026/3/31
2026-04-01查看详情 >
